Feb 16, 2024· Comment from Animal Health Institute (AHI)· FDA-2023-D-3740-0004
The ANIMAL HEALTH INSTITUTE (AHI) appreciates the opportunity to comment on CVM Guidance for Industry #283 Priority Zoonotic Animal Drug Designation and Review Process. Please see the attached comments.